U.S. Court of Appeals for the Federal Circuit, 2025

Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company

Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company
U.S. Court of Appeals for the Federal Circuit · Decided September 8, 2025

Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company

Opinion

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA PHARMACEUTICALS USA, INC., Appellants v. ELI LILLY AND COMPANY, Appellee ______________________ 2024-1094 ______________________ Appeal from the United States District Court for the District of Massachusetts in No. 1:18-cv-12029-ADB, Judge Allison Dale Burroughs.

------------------------------------------- TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA PHARMACEUTICALS USA, INC., Plaintiffs-Appellees v. ELI LILLY AND COMPANY, Defendant- Appellant ______________________ 2024-1149 ______________________ 2 TEVA PHARMACEUTICALS INTERNATIONAL GMBH v. ELI LILLY AND COMPANY

Appeal from the United States District Court for the District of Massachusetts in No. 1:18-cv-12029-ADB, Judge Allison Dale Burroughs.

______________________ ORDER Teva Pharmaceuticals International GmbH, Teva Phar- maceuticals USA, Inc, and Eli Lilly and Company stipulate to voluntary dismiss Appeal No. 24-1149.

The parties, having so agreed, IT IS ORDERED THAT: (1) Appeal No. 24-1149 is dismissed under Fed. R. App. P. 42(b), with each side to bear their own costs. (2) The official captions as modified, are reflected in this order.

FOR THE COURT

September 8, 2025 Date

ISSUED AS A MANDATE (as to Appeal No. 24-1149 only): September 8, 2025.

Case-law data current through December 31, 2025. Source: CourtListener bulk data.